House panel assesses agencies' progress in implementing opioid laws

Oct 25, 2017 - 10:13 AM

The House Energy and Commerce Committee today held a hearing on the administration’s progress in carrying out provisions of the Comprehensive Addiction and Recovery Act and the 21st Century Cures Act, enacted last year to address the opioid epidemic. Lawmakers on both sides of the aisle criticized the Drug Enforcement Administration for delays in responding to committee inquiries about the agency’s enforcement of alleged “pill dumping” by manufacturers. Members also questioned federal agency heads about the higher cost of easily administered forms of opioid overdose reversal medicine, the percentage of addiction cases that are due to legally prescribed versus illegal drugs, and whether Congress should enact stronger criminal penalties for overprescribing of opioids. In a statement submitted to the committee, AHA recommended several federal actions to address the opioid crisis, including eliminating the Medicaid Institutions for Mental Disease exclusion for adults under age 65.

Related News Articles

Headline
CMS to update SPA template for medication-assisted treatment benefit
The Centers for Medicare & Medicaid Services today released a notice seeking public comment on the collection of information request regarding the State…
Headline
FDA approves first-in-class non-opioid painkiller 
The Food and Drug Administration Jan. 30 announced it approved Journavx (suzetrigine) oral tablets, a first-in-class non-opioid drug, to treat moderate to…
Headline
AHA podcast: Englewood Health's Strategies to Combat Rising Opioid Use in Post-Pandemic America
In this conversation, Vinnidhy Dave, D.O., hospice specialist and director of palliative medicine at Englewood Health Physician Network, and Lauren Savage,…
Headline
AHA podcast: Thinking Outside the Box to Reduce Behavioral Health Stigma and Disparities 
In this conversation, Matthew Hoag, director of integrated behavioral health at Denver Health, shares how the organization is innovating through integration to…
Headline
'Take Back Day' Oct. 28 to dispose safely of prescription drugs
Oct. 28 is National Prescription Drug Take Back Day, an opportunity for the public to safely dispose of unwanted or expired tablets, capsules, patches and…
Headline
Agencies target unapproved pharmaceutical products from India
Federal agencies last month stopped over 500 unapproved pharmaceutical products and medical devices, including opioid and other controlled substances, from…